The in vivo revolution in CAR-T therapy medicinal products: challenges and regulatory prospects
{{output}}
Chimeric antigen receptor T-cell (CAR-T) therapy, a groundbreaking advancement in cancer immunotherapy, has demonstrated remarkable efficacy in treating hematological malignancies and autoimmune diseases. However, conventional ex vivo CAR-T therapy medicinal p... ...
